Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: Rationale for different risk-adapted treatment

European Urology

Volumn 33, Issue 6, 1998, Pages 562-566

  Ondrus, D ^a   Matoska, J ^a   Belan, V ^a   Kausitz, J ^a   Goncalves, F ^a   Hornak, M ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Adjuvant chemotherapy; Prognostic factors; Retroperitoneal lymph node dissection; Surveillance policy; Testicular cancer stage I; Vascular invasion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FOLLOW UP; GERM CELL TUMOR; HEALTH CARE POLICY; HISTOPATHOLOGY; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; TESTIS CANCER; TESTIS TERATOMA;

ADOLESCENT; ADULT; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; ORCHIECTOMY; PROGNOSIS; RETROPERITONEAL SPACE; RISK FACTORS; SURVIVAL RATE; TESTICULAR NEOPLASMS;

EID: 0031802070     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019656     Document Type: Article

References (27)